Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Timing matters: automatic rebalancing should occur as your allocations drift beyond set thresholds.
18,157 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Advance Auto Parts stock jumped today after stronger-than-expected quarterly results. This article breaks down the ea...
The AI boom often centers on GPUs and big models, but the true mover is the network that ties data and compute togeth...
As mortgage rates and prices wobble, first-time buyers face a tougher path. Experts urge a disciplined plan and reali...
China is reshaping higher education by cutting arts degrees to prioritize AI-ready programs. Industry leaders urge fa...
AVX's Q4 2025 results shed light on growth, profitability, and the path ahead. This article breaks down the numbers, ...
Two oil giants enter 2026 with contrasting plays: Occidental Petroleum pares back, focusing on the Permian, while Exx...
Explore what Q1 2026 earnings could mean for American Eagle Outfitters. This guide breaks down revenue, margins, and ...
Shares in American Eagle Outfitters slid after a disappointing quarterly report. This guide breaks down the key drive...
Investing in Micron today means evaluating AI-driven memory demand, pricing power, and the memory market cycle. This ...
The AI boom is reshaping markets, and Nvidia sits at the center. This article lays out three concrete reasons why now...
A small-cap data services company sparked May’s AI rally, with Innodata surging nearly 150% after a solid earnings re...